Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2000 Jan 24;14(1):13–16. doi: 10.1002/(SICI)1098-2825(2000)14:1<13::AID-JCLA3>3.0.CO;2-C

Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) Type 1‐specific and HSV Type 2‐specific IgG antibodies

Harry E Prince 1,, Carolyn E Ernst 1, Wayne R Hogrefe 1
PMCID: PMC6808085  PMID: 10645979

Abstract

MRL Diagnostics has developed a dual enzyme immunoassay (EIA) system that employs the recombinant Herpes Simplex Virus (HSV) type‐specific glycoproteins G1 (HSV1) and G2 (HSV2) to detect HSV type‐specific IgG antibodies. This system was evaluated using 155 consecutive sera previously tested in a conventional dual EIA system (Zeus) that employs multiple HSV1 and HSV2 proteins to detect type‐common as well as type‐specific antibodies. Sera were also analyzed by Western blot to determine the true HSV type‐specific IgG reactivity pattern. Of 110 sera giving concordant reactivity patterns in the MRL and Zeus EIA systems, 108 (98%) also displayed concordant Western blot patterns; two sera gave false positive HSV2 reactivity in both EIA systems. Of 45 sera giving discordant MRL and Zeus EIA reactivity patterns, 41 (91%) displayed a Western blot reactivity pattern that matched the MRL reactivity pattern. Both the HSV1 IgG component and the HSV2 IgG component of the MRL EIA system were 100% sensitive and > 95% specific. In contrast, the Zeus HSV1 IgG EIA was 98% sensitive and 79% specific, and the Zeus HSV2 IgG EIA was 85% sensitive and 79% specific. An analysis of the distribution of index values in the MRL EIA system showed that low‐positive values (1.0–3.0) were rare, but, when detected, often represented false positive results; only 11 MRL low‐positive results were observed, but all 6 MRL false positive results were found within this low‐positive subgroup. These findings show that the MRL dual EIA system effectively detects HSV type‐specific IgG antibodies. J. Clin. Lab. Anal. 14:13–16, 2000. © 2000 Wiley‐Liss, Inc.

Keywords: herpes simplex virus, type‐specific IgG, enzyme immunoassay

REFERENCES

  • 1. Schmid DS, Brown DR, Nisenbaum R, et al. Limits in reliability of glycoprotein G‐based type‐specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol 1999;37:376–379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Ashley R, Cent A, Maggs A, et al. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 or 2. Ann Intern Med 1999;115:520–526. [DOI] [PubMed] [Google Scholar]
  • 3. Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. New Engl J Med 1995;333:770–775. [DOI] [PubMed] [Google Scholar]
  • 4. Mindel A. Genital herpes—how much of a public‐health problem? Lancet 1998;351(Suppl. III):16–18. [DOI] [PubMed] [Google Scholar]
  • 5. Hashido M, Lee FK, Inouye S, Kawana T. Detection of herpes simplex virus type‐specific antibodies by an enzyme‐linked immunosorbent assay based on glycoprotein G. J Med Virol 1997;53:319–323. [DOI] [PubMed] [Google Scholar]
  • 6. Whitley RJ, Kimberlin DW, Dernard R. Herpes simplex viruses. Clin Infect Dis 1998;26:541–555. [DOI] [PubMed] [Google Scholar]
  • 7. Arvin AM, Prober CG. Herpes simplex virus type 2—a persistent problem. New Engl J Med 1997;337:1158–1159. [DOI] [PubMed] [Google Scholar]
  • 8. Cowan FM, Johnson AM, Ashley R, et al. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis 1996;174:470–475. [DOI] [PubMed] [Google Scholar]
  • 9. Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type‐specific serology. Clin Microbiol Rev 1999;12:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Ho DWT, Field PR, Sjogren‐Jansson E, et al. Indirect ELISA for the detection of HSV‐2 specific IgG and IgM antibodies with glycoprotein G (gG‐2). J Virol Methods 1992;36:249–264. [DOI] [PubMed] [Google Scholar]
  • 11. Lee FK, Coleman RM, Pereira L, et al. Detection of herpes simplex virus type 2‐specific antibody with glycoprotein G. J Clin Microbiol 1985;22:641–644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Lee FK, Pereira L, Griffin C, et al. A novel glycoprotein for detection of herpes simplex type 1‐specific antibodies. J Virol Methods 1986;14:111–118. [DOI] [PubMed] [Google Scholar]
  • 13. Ashley RL, Wu L, Pickering JW, et al. Premarket evaluation of a commercial glycoprotein G‐based enzyme immunoassay for herpes simplex virus type‐specific antibodies. J Clin Microbiol 1998;36:294–295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Groen J, Van Duk G, Niesters HGM, et al. Comparison of two enzyme‐linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type 2‐specific antibodies in serum. J Clin Microbiol 1998;36:845–847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Ashley R, Militoni J, Lee F, et al. Comparison of Western blot (immunoblot) and glycoprotein G‐specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 & 2 in human sera. J Clin Microbiol 1988;26:662–667. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES